The efficacy and safety of cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: A comparative analysis of retrospective studies versus prospective studies.

Wang, Bi-Cheng; Xiao, Bo-Ya; Kuang, Bo-Hua; Lin, Guo-He

Wang, Bi-Cheng; Xiao, Bo-Ya; Kuang, Bo-Hua; Lin, Guo-He.

Afiliação

Wang BC; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiao BY; Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
Kuang BH; Department of Medical Psychology, Faculty of Psychology, Naval Medical University (Second Military Medical University), Shanghai, China.
Lin GH; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Dermatol Ther ; 35(9): e15715, 2022 09.

Article em En | MEDLINE | ID: mdl-35821497

Assuntos

Carcinoma de Células Escamosas; Neoplasias Cutâneas; Anticorpos Monoclonais Humanizados; Carcinoma de Células Escamosas/tratamento farmacológico; Carcinoma de Células Escamosas/patologia; Humanos; Estudos Prospectivos; Estudos Retrospectivos; Neoplasias Cutâneas/tratamento farmacológico; Neoplasias Cutâneas/patologia

Palavras-chave

analysis; cemiplimab; cutaneous squamous cell carcinoma; efficacy; safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google